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Abstract.  We recently described the identification of 
BOS1  (Newman, A., J.  Shim, and S. Ferro-Novick. 
1990. Mol.  Cell.  Biol.  10:3405-3414.).  BOS1 is a gene 
that in multiple copy suppresses  the growth and secre- 
tion defect of bet1 and sec22, two mutants that disrupt 
transport from the ER to the Golgi complex in yeast. 
The ability of BOS1 to specifically suppress mutants 
blocked at a particular stage of the secretory pathway 
suggested that this gene encodes a protein that func- 
tions in this process.  The experiments presented in 
this study support this hypothesis. Specifically,  the 
BOS1 gene was found to be essential for cellular 
growth. Furthermore, cells depleted of the Bosl pro- 
tein fail to transport pro-or-factor  and carboxypeptidase 
Y (CPY) to the Golgi apparatus. This defect in export 
leads to the accumulation of an extensive network of 
ER and small vesicles.  DNA sequence analysis pre- 
dicts that Bosl is a 27-kD protein containing a puta- 
tive membrane-spanning domain. This prediction is 
supported by differential centrifugation experiments. 
Thus, Bosl appears to be a membrane protein that 
functions in conjunction with Betl and Sec22  to facili- 
tate the transport of proteins at a step subsequent to 
translocation into the ER but before entry into the 
Golgi apparatus. 
T 
HE process of vesicle-mediated transport  is complex 
and involves several events. Carrier vesicles, contain- 
ing contents destined to traverse the secretory  path- 
way, bud from a donor membrane.  These vesicles are then 
targeted to their acceptor compartment where they bind to 
and fuse with this membrane to permit the mixing of con- 
tents (Palade, 1975). How a transport vesicle is formed and 
how it delivers its cargo to the correct acceptor organelle are 
pivotal  questions  regarding  the  mechanism  of membrane 
traffic  that remain  unanswered.  Although  little  is  known 
about the molecular details underlying the budding, target- 
ing, and fusion events, it is assumed that the regulation and 
specificity of  these processes are ensured by proteins. There- 
fore,  a  prerequisite  to addressing  the mode of vesicular 
traffic is the identification and characterization of  these com- 
ponents. 
Classical genetic studies in the yeast Saccharomyces cere- 
visiae have defined 11 SEC and BET genes whose products 
are required for the transport of proteins from the lumen of 
the ER to the Golgi complex (Novick et al., 1980; Newman 
and Ferro-Novick,  1987). The SEC and BET gene products 
may participate in the budding of vesicular carriers from the 
ER or their subsequent binding and fusion with the Golgi ap- 
paratus. The recent development of assays that faithfully re- 
produce these events in vitro (Ruohola et al.,  1988; Baker 
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et al., 1988) should facilitate studies aimed at elucidating the 
function of the See and Bet proteins. 
We have described the isolation of  a new gene, BOS1 (betl 
one suppressor),  that suppresses the growth and secretion 
defect ofbetl and sec22 (Newman et al., 1990). The ability 
of this gene to specifically suppress two different secretory 
mutants,  that disrupt  transport  from the ER to the Golgi 
complex, suggests that its product functions in this process. 
In this report, we show that the BOS1 gene encodes a 27-kD 
protein containing a putative membrane  spanning domain. 
To test the function of Bosl, we have constructed a strain in 
which the synthesis of this protein is under the control of the 
regulatable GAL/promoter.  Here we demonstrate that yeast 
cells depleted of Bosl fail to transport pro-~-factor and car- 
boxypeptidase Y to the Golgi complex. This defect in trans- 
port leads to an extensive accumulation of ER and patches 
of small vesicles. These findings support the hypothesis that 
the BOS1 gene product is one of several proteins mediating 
transport  at this stage of the secretory  pathway. 
Materials and Methods 
Growth Conditions 
Yeast cells were grown in YP~ medium (1% Bacto-yeast extract and 2% 
1.  Abbreviations  used  in  this  paper:  CPY, carboxypeptidase  Y;  LB, 
Luria-Bertani medium; YP, 1% Bacto-yeast extract and 2% Bacto-peptone. 
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Strain  Genotype  Source 
NY363  MATa/ot, leu2-3,  112/+,  ura3-52/ura3-52,  his4-619  P.  Novick* 
SFNY59  MATa,  ura3-52,  pRB307 (2/~m,  URA3)  This study 
SFNY61  MATa,  ura3-52,  pFNB61  (2 #m,  URA3, BOS1)  This study 
SFNY26-6A  MATot, his4-619  This laboratory 
NY447  MATs,  ura3-52,  GAL  ÷, his4-619  This study 
JSY1  MATa,  GAL  +, his4-619,  GAL1-BOS1  This study 
ANYll3  MATot, ura3-52,  his4-619,  bet1-1  This laboratory 
NY432  MATot, ura3-52,  sec18-1  P.  Novick* 
SFNY85-1B  MATa,  ura3-52,  GAL  +, betl-1  This study 
SFNYg6-7B  MATa, ura3-52,  GAL  +, sec22-3  This study 
SFNY87-4D  MATa his4-619,  GAL  +, bet1-1,  GAL1-BOS1,  This study 
SFNY8g-5c  MATot, his4-619,  GAL  +, sec22-3,  GAL1-BOS1  This study 
* Department of Cell Biology, Yale University School of Medicine. 
Bacto-peptone) with 2 % glucose or in Wickerham's minimal medium (Wick- 
erham,  1946) supplemented with the appropriate nutrients (20 ~g/ml of 
histidine, 40 pg/ml of uracil).  For sulfate-free minimal medium, all sulfate 
salts were replaced  with chloride salts. JSY1 was grown in YP or minimal 
medium with 0.5% galactose and 2% raltinose. To change growth medium, 
cells were pelleted in a clinical tabletop centrifuge at room temperature and 
resuspended in fresh medium.  Cell densities were  measured in a  1-cm 
quartz cuvette at a wavelength of 599 am in an LKB Biochrom Ultro Spec 
Plus spectrophotometer (LKB Instruments, Gaithersbnrg, MD). 
Genetic Techniques and Constructions 
All plasmids constructed were transformed into Escherichia coli (DHI) to 
amplify DNA.  Ampicillin resistant transformants were selected  in Luria- 
Bertani medium (LB) plates containing ampicillin (100/~g/ml).  Plasmid 
DNA extracted  from E. coli (Biruboim and Doly,  1979) was transformed 
into Ura- yeast strains using lithium alkali cation treatment (Ito et al., 
1983). 
Several plasmid constructions were required to construct JSY1, a strain 
in which the BOS1 gene was placed under the control of the regulatable 
GAL/promoter. The scheme used to construct this strain is summarized in 
Fig. 5. Plasmid pYG1 was constructed as follows: pNRB187 (Table II) was 
cut with Barn HI, the 3' recessed end was filled in using the E. coli pol I 
Klenow fragment, and the vector was gel purified and treated with alkaline 
phosphatase. A 0.26-kb Taq I-Ava II fragment, containing the amino termi- 
nus ofBOS1 -~ to 195, was excised from pNF13 and blunt end-ligated  into 
the Barn HI site ofpNRB187.  To construct pYG2, a 1.05-kb Eco RI fragment 
from pYG1, containing the GALI-BOS1  '69 to I~ fusion, was then inserted 
downstream from URA3 into the Eco RI site of pNRB103. Plasmid pYG3 
was constructed as follows: pYG2 was digested with Nhe I, the recessed  3' 
end was filled in using Klenow and the vector fragment was gel purified and 
treated with alkaline phosphatase. A  1.7-kb Kpn I fragment, upstream of 
BOS1, was excised from pFN8 (Table II) and blunt end-ligated in the correct 
orientation  into the N-he  I site of pYG2. Lastly, pYG3 was digested with BgllI 
and partially digested with Eco RI to obtain the 4.0-kb Bgl II-Eco RI frag- 
ment shown in Fig.  5.  This fragment was transformed into NY 477 and 
Ura  + transformants were selected. 
Plasmid pTB1, which contains TrpE fused  to an internal fragment of 
BOSI,  was constructed as  follows:  pFN13  (Table II) and pATH10 were 
digested with San 3A and Barn HI, respectively,  and then electrophoresed 
into an agarose gel.  The 0.44-kb Sau3A fragment (nucleotide  329-769  of 
the BOSI gene) and the pATH10 vector were purified from an agarose gel 
and the purified  fragments were religated  and used to transform E.  coli 
(DH1). The TrpE-BOS1 fusion protein contains 147 of the 244 amino acids 
encoded by the BOS1 gene product. 
DNA Sequence Analysis and Homology Search 
To determine the DNA sequence of the Kpn I-Nco I fragment which con- 
tains the BOS1 gene, restriction fragments were cloned into the polylinker 
site of M13 phage derivatives (mpl8 and mpl9; Dale et al.,  1985) and the 
nucleotide  sequence was  determined by the dideoxy  chain termination 
method (Sanger  et al.,  1977) using the Sequenase  DNA sequencing  kit 
(United States Biocbemicals Corp., Cleveland,  OH). For each sequencing 
reaction the replicated DNA was labeled with 5 #Ci of [~-35S]dATP. All 
sequencing  reactions were electrophoresed at 1,500 V on 8% polyacryl- 
amide gels (40:1.3, acrylamidedbisaerylamide),  containing 8 M urea, and 
the dried gels were exposed to Kodak XAR-5 film for 24 h. The BOSI se- 
quence was compared with that of other proteins entered into the National 
Biomedical Research Foundation protein sequence library. The FASTA and 
Table II. Plasmids 
Plasmid  Derivation 
pFN8 
pFN13 
pFN14 
pTB1 
pRB8 
pNRBI03 
pNRB 187 
pYG1 
pYG2 
pYG3 
pFNB61 
YCp50,  BOS1;  4.2-kb SphI fragment from pAN105 (Newman et al.,  1990) inserted in the Sph I site 
YCp50,  BOS1; 2.2-kb Hinc II-Nco I  fragment from pAN105  inserted in the Hind III (blunt) site of the vector 
YCp50, BOSI::URA3 gene disruption;  1.1-kb Hind III fragment (URA3) inserted in the internal Eco RI (blunt) site of 
BOS1  in pFN8 
pATH10,  TrpE-BOS1329769 fusion; 0.44-kb Sau3A fragment from pFNI3  inserted in the Bam HI site 
pBR322;  1.1-kb Hind III fragment (URA3) inserted in the Hind HI site 
YCp50,  1.1-kb Hind HI fragment (URA3) inserted in the Hind HI site 
YCp50,  with GALl promoter; 0.82-kb Eco RI-Bam HI fragment inserted in the Eco RI-Bam HI site; expression under 
GALl  control by cloning into the Barn HI site 
YCp50,  GAL1-BOS1 ~gt° ~95 fusion, 0.26-kb Taq I-Ava II fragment (amino terminus of BOS1)  from pFN13  inserted in 
the Barn HI (blunt) site of pNB187 
YCp50,  GAL1-BOS1 -~9 to ~  fusion;  1.05-kb Eco RI fragment from pYG1  inserted in the Eco RI site of pNB103 
YCp50,  GAL1-BOS1 ~9 ,o ~;  1.7-kb Kpn I  fragment (upstream region of BOS1 ) from pFN8 inserted into the 
Nhe I  (blunt) site of pYG2 
2  tzm, BOS1,  15-kb Sal I  fragment from pAN105,  in the Sal I  site of vector, pRB307 (from the collection of D.  Botstein, 
Stanford University) 
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(Lipman and Pearson, 1985). 
Preparation of the TrpE-Bosl Fusion Protein, 
Rabbit Immunization, and Affinity Purification of 
the Anti-Bosl Antibody 
SFNB16 (DH1 transformed with pTBI) was grown as described previously 
by Goud et al.  (1988).  Cells from a 200 ml culture (OD599 ,u0.5)  were 
pelleted and washed with 50 ml of 20 mM Tris-HC1 (pH 7.0). The pellet 
was resuspended in 5 ml of cracking buffer (10 mM sodium phosphate, pH 
7.2,  1% SDS, 6 M urea,  1% ~-mercaptoethanol) and incubated for 2 h at 
37"C. DNA was precipitated from the sample by centrifuging the lysate for 
30 min at 20,000  rpm in a Ti 50 rotor (Beckman Instruments, Inc., Palo 
Alto, CA).  The supernatant was mixed with concentrated sample buffer 
(Laemmli, 1970) and electrophoresed on a preparative 8% SDS polyacryl- 
amide gel. The gel was stained for protein and destained. The fusion protein 
was excised from the gel and the gel stripe, containing the fusion protein, 
was washed several times with distilled water over the course of 2 h. The 
sample was chopped into small cubes and the hybrid protein was electro- 
eluted from the gel at 100 V for 12 h onto dialysis membrane (Hunkapillar 
et al.,  1983). This procedure yielded ,vS00 ttg of fusion protein in 0.5 ml 
of dialysis buffer which was stored at -20"C. 
The immunization protocol used was essentially the same as described 
by Louvard et al. (1982).  The serum was affinity  purified  on an Affigel 
column to which the TrpE-Bosl  hybrid protein was cross-linked.  The pro- 
tocol used was described by Gond et al. (1988). This procedure yielded 1.5 
nag of purified antibody in a volume of 2.5 mi. 
In Vivo Labeling and lmmunoprecipitation 
Cells were grown to early exponential  phase at 30"C in minimal medium 
containing I00 izM ammonium sulfate,  0.5% galactose,  2% raflinose,  40 
t~g/ml uracil, and 20 tLg/ml L-histidine. To repress transcription from the 
GA/3 promoter, JSY1 cells were pelleted and resuspended (OD599 ffi 0.025) 
in medium containing 2% glucose as the sole carbon source. After 12 h of 
growth at 30"C (approximately  six doublings),  the OD~99 of JSY1 failed to 
increase.  At this point,  one ODs99 of wild type and JSYI  cells were 
pelleted and resuspended in 0.5 ml of minimal medium, which was sup- 
plemented with 25 t~M ammonium sulfate, 2 % glucose,  nutrients, and 200 
~Ci of [35S]sulfate. The cells were incubated for 45 min at 300C and ly- 
sates were prepared and processed for immunoprecipitation as described 
below. 
The bet and sec mutants were grown to early exponential phase at 25°C 
in minimal medium supplemented with 100/~M ammonium sulfate and 2 % 
glucose.  One OD~99 of cells were pelleted, resuspended in 0.5 mi of the 
same medium containing 25 I~M ammonium sulfate and incubated for 15 
rain at 37"C. After this incubation, 135S]sulfate  (200 t~Ci) was added to the 
medium and the incubation was continued for 45 rain. The radiolabeled 
ceils  were  washed with I ml of  cold 10  mM  sodium  azide,  resuspended  in 
spheroplast  medium (1.4  M  sorbitol,  50  mM potassium  phosphate  (pH  7.5), 
I0 mM  sodium azide,  and 36 mM  ~-mercaptoethanol)  containing  I U of 
zymolyase 1001"  and incubated  for I h at 30"C. The spheroplasts  were 
pelleted,  lysed  in  I00/~l  of  I% SDS,  and  heated  to  100*C  for  3  rain.  Lysates 
were diluted  with 900 pl of  dilution  buffer  (0.2  M  sodium chloride,  12.5 
mM  potassium phosphate,  pH 7.5,  2  % Triton  X-100) and centrifuged  for 
15 rain  in an eppendorf centrifuge  at  4°C. The supernatant  (800 #l) was 
removed  and  added  to  an  Eppendorf  tube  containing  2 #l  of  the  appropriate 
antibody.  Protease  inhibitor  cocktail  (Waters  and Blobel,  1986)  was  added 
and the incubation  was continued  for 16 h at  40C. The antigen-antibody 
complexes were  precipitated  with  Protein  A-Scpharose  (60  ~l  of  a 10% so- 
lution)  during  a  90-min  incubation  at  4°C and  the  beads  were  washed  three 
times  with  urea  wash  buffer  (2  M urea,  200 mM  sodium  chloride,  100  mM 
Tris  pH 7.6 and 1% Triton  X-100) and three  times  with  I% /~-mercapto- 
ethanol.  The washed Protein  A Scpharose beads were heated  in  Laemmli 
sample buffer  at 100*C for 3 rain  and subjected  to SDS-PAGE (I0 or 
12.5%). Tbe samples were normalized  to compare strains;  the  amount of 
sample loaded  onto  the  gel  was based  on  the [35S]sulfate  incorporated  into 
the  total  lysate. 
High  molecular  weight  markers used for  SDS-PAGE were  205-kD myo- 
sin,  116-kD  fl-galactosidase,  97.4-kD phosphorylase  B,  66-kD  BSA, 45-kD 
ovalbumin,  and  29-kD  carbonic  anhydrase.  Low molecular  weight  markers 
were 66-kD BSA, 45-kD ovalbumin,  36-kD glyceraldehyde-3-phosphate- 
dehydrogenase,  29-kD carbonic anhydrase,  24-kD trypsinogen,  20.l-kD 
trypsin  inhibitor,  and 14.2-kD a-lactoalbumin.  Dried  gels  were  exposed  to 
preflashed  Kodak XAR-5 film. 
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Figure  1.  Restriction map of the Kpn I-Nco  I  fragment and se- 
quencing strategy. The coding sequence of the BOS1 gene is shown 
as a heavy black arrow. The putative intron, located immediately 
after the first codon, is stippled. 
Results 
Nucleotide Sequence of the BOS1 Gene 
Our  previous  studies  have  shown  that  BOS1, BETI  and 
SEC22 are members of a group of interacting yeast genes 
(Newman et al.,  1990).  As a first step toward determining 
the function of Bosl, we cloned and sequenced the gene that 
encodes this protein. BOS1 was identified by its ability to 
partially suppress the bet1 mutant at 37°C.  Yeast genomic 
fragments containing this gene were described previously 
(Newman et al., 1990) and a 2.2-kb Hinc II-Nco I genomic 
insert, that suppressed bed to the same extent as the original 
isolate, was the smallest reported clone. This insert was sub- 
cloned to a 1.4-kb Kpn I-Nco I fragment and the nucleotide 
sequence  of this  region  was  determined by  the  strategy 
shown in Fig. I. The 244-amino acid (27-kD) protein (called 
Bosl), contained within this fragment, suppressed the bet1 
and sec22 mutants (see Fig. 6). The BOS1 gene contains a 
putative 88-bp intron with 5'(GTATGT) and 3' consensus se- 
quences  for yeast RNA  splicing  (Langford et  al.,  1984; 
Padgett et al.,  1986).  Fig. 2  shows that this 5' consensus 
splice  site follows the first codon of BOS1 and the yeast 
branch point box (TACTAAC) is 47 nucleotides downstream 
from the splice site. The predicted 3' splice site is 25 nucleo- 
tides downstream from the branch point box. 
DNA sequence analysis predicts that the amino terminus 
of the Bosl protein is hydrophilic with a hydrophobic stretch 
of 18 amino acids 4 amino acids from its carboxy terminus. 
This hydrophobic region is flanked by basic residues that 
may associate with negatively charged head groups of a 
phospholipid bilayer to anchor Bosl  to a membrane. The 
DNA sequence also predicts one potential N-linked glycosy- 
lation site (at amino acid position 99) preceding the hydro- 
phobic carboxy terminus.  Since the primary sequence of 
Bosl does not contain a structure resembling a classical sig- 
nal peptide, this protein may not enter the lumen of the ER 
where it would become accessible to the glycosylation ma- 
chinery. Thus, this site may not be used.  Further experi- 
ments will be needed before any final conclusions can be 
drawn. 
BOSI Is an Essential Gene 
Since many of the genes required for protein transport per- 
form an essential function, we have determined if BOS1 is 
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-30_0  -290  -2~.0  -270  -260  -2~.0 
GOT  ACCT  AGTCCCTCTOOACCTTOOTOOOOTO0  AAOOAOTC  ATTTTCOTOTAAT  AnTCCC 
-24_0  -210  -2Zo  -2£0  -290  -I 2o 
TGCTTCAAGGGTCAAAATTCCOT AGAGGTTTOOTTOATTOATTT ACAAAOACAAT  ACCTT 
-LO.o  -IZO  -I~_0  -I~.0  -I~o  -11o 
ATCCTTTGG  AT  ATGCCTTCTCTCTTTTTAT  AAAT  ATCAAAAGTTGCGACOCGAACAAC/~k 
-~Zo  -U.o  -T~o  -20  -~.0  -7-0 
GCC  AGCC  ATTG  AA  ATTTC AGTaTGCTGGCTAT  AATAGACAGGATCGACGCTOTCGATGGA 
-~o  -~.o  -4..o  -lO  -~  -1_o 
O  A AGG  A  A  AC  ACGGC  AATAOTGC  AGAT ATTATCGTG  ACTTAATCAT ATTGATTTGAGGGGO 
i  j.o  zo  to  40  ~0 
OA ATG  GTATGTTTGATCOCOOAGGCATCTTTTCTCATTATTGCTAAAACAAGATOTAATA 
6-0  Zo  ~o  2o  1~o  I£o 
CTAACAOOOTATTTTOCT~CTACCATCAAATAO  AAe  OCT  CTT  TAC AAC  CAT  OCT  arO AAO 
I~0  I~0  1,40  I~.0  160  r¢oRl  17.0 
CAA  AAA AAT CAA CTA CAA CAA GAG TTO OCC AGG TTT 0AA AAG AAT TCT GTG ACC GCC CCT 
91n  19s  ash  gln  leu  91n  91n  91u  leu  ill  ar9  phe  (Jlu 19s  asn  set  val  thr  a14  pro 
18_0  19_0  200  21_0  2~0  230 
ATT TCT TTA CAA ~G TCC ATC TCT 6CA ACT CTO OTC TeA CTO OAO AAA kCk nT'r AAO CAA 
ile  set  leu  91n  gl~i  set*  fie  set" a1~  thr  leu  val  se~  leu  glu  ~s  the  v~1  19s  91~ 
240  2~.0  26_0  270  2~.0  220 
TAT GCA GAA CAT TTA AAC AGA TAT AAA GAA GAT ACT AAT GCA GAG GAA ATT GAT CCT AAG 
t~Ir  ala  9}u  his  leu  ash  *Ir  9  tgr  19s  glu  4sp  thr  .ISn ala  91u  glu  ile  ~sp  pro  IQs 
300  31.o  ~Zo  ~-0  ~io  ~-0 
TTC  GCT AAT CGA CTA GCA ACT TTA ACA CAG GAT CTG CAC OAC TTT ACT OCC AAG TTT AAG 
phe  ill  isn  Ir9  leu  11~  thr  leu  thr  gin  ISp  le~J  his  Isp  phi  thr  ill  IVS  phe  l~s 
36_0  370  38_0  320  400  410 
GAT TTA AAA CAA TCC TAC  AAC OAA AAT AAT TCC AGA ACT CAO TTO TTT oGC TCA GGA OCk 
~sp  leu  l~s  gln  ser  tVr  ash  glu  ash  esn  set  ~rg  thr  gln  leu  phe  91~  set" gl~  ala 
~z_o  ~o  4~.o  ~  4.6.0  47_0 
rCG CAr OTT A~O OAC TCC 0~  ~AC CCC TTT AOT ~C~ TCA OAG ~CC Arc ATO ~X  ~A  ~OO 
ser  his  wl  met  ~sp  ser  asp  ~sn  pro  phe  set  thr  set  ¢1u  thr  fie  met  ash  Igs  arg 
~go  ~_0  5.0.0  ~10  5ZO  s!o 
A  AC GTT  GOT GOT GCO AGT OCA AAT ~T  AAA GAG OGC TCT A(~C AAC GGT GGG OGA CTA (:CO 
ash  val  91~  91U  ala  set  all  asrt  919  lys  91u  9~  ser  ser  ash  919  91y  91y  leu  pro 
~4-0  s~.o  ~o  ~ZO  ~.o  ~9_o 
TTG TAC CAA OOO CTA CAA AAG OAA CAG TCT OTT TTC OAk AOG OOT kkC GCT Ckk TTA OAT 
leu  tyr  91n  91~/ leu  91n  lys  glu  gl~  Set  vll  phe  91u  Irg  919  ash  ~11  gln  leu  asp 
69o  61.o  t~Zn  6~o  6~  6~.o 
TAC ATT CTA GAA ATO OC~ CAA CAA TCA TTC OAk AAT ATA GTO OAA CAA AAC AAA ATT TTA 
t~r  ile  leu  91V  met  9~  9  In  9  ~  s~t" phe  9lu  ~sr~  i~  v~l  g~u  g~  ash  19s  ile  leu 
6~.0  670  6e-0  620  7~o  710 
TCC AAO OTA CAA OAT AOA ATO TCA AAT OOC CTA ~A  ACA TTO OOT GTT TCO OAA CAA ACT 
ser  I~s  val  91n  asp  arg  met  set"  aim  91~  leu  arg  thr  lou  9N  vll  set" 9kl  91n  tl~ 
72_o  7!o  74_o  7~o  7~o  770 
ATC ACC TCT ATC AAT AAA CGG GTG TTC AAA GAT AAA CTA GTC TTT TGG ATC GCG TTA ATT 
ile  thr  ~er  i1~  ~sn  lvs  ~r9  wl  phe  lvs  ~sp  lvs  le~ val pbe trp  ile ~la  le~  ile 
7go  7~o  e~o  aJ.O  eZO  s!o 
CTC TTO ATC ATA GOT ATT TAT TAT OTO TTO AAA TOO TTA AOA TAO AAO TAA CCO TGA OTT 
leu  levi  lie  fie  gl~l  fie teJr tyr  val leu  l~s  trp  leu  arg  stop  stop  stop 
e~.o  e~.o  e~.o  e'to  eeo  e2o 
CT  AT  AT AT  AOATA AAC  AT ACC AT ATATACATOC ATCATT ATAAGOGTTOAAA  AA  AC  ATCC 
9~o  9J.O  ~Zo  ~Io  ~Io  ~.o 
O  A  ATCTCGCT  ACTTTCCTTCT  ATGCTCTTTCGTTTCTC  A  A ACCCOCC  AOT  AT k AGC A  ACT 
~6_o  ~7-o  9go  e2o  1  o~o  ~  olo 
TTT  A  TT  ACC ATTGOTGACT ACACOTTGCTCCTTTTTT AAOTGT AATTT  ACTGTT A  T AAA  T 
10_20  I o~o  I olo  I o~o  t o~o  1070 
TGAGTCCAAATCTOTCGTOTCTTOTCCT~TTTOAOAACTTCOOGAATGTTCATTGCTTA 
I  O_aO  1020  1100  1110  Noel 
GCGC  ATTTCAT AGTTTTCTTrCC AATACCTAOTTTGC~C  ATQ~ 
Figure 2.  DNA sequence  of the Kpn I-Nco I fragment. The se- 
quence of the 1.4-kb Kpn I-Nco I fragment, containing the BOS1 
gene,  is  shown.  Promoter  elements  such  as  the  upstream  A:T 
stretch  and TATA box are underlined.  The intron is denoted by 
asterisks  and the 5' and  3' splice sites  as well as the branch point 
consensus  sequences  are in boldface.  The amino acid sequence  is 
shown  below  the nucleotide sequence.  Lastly,  a potential  mem- 
brane-spanning  domain of 18 hydmphobic amino acids,  located at 
the COOH terminus of the predicted  protein, is shown in boldface. 
These sequence data are available  from EMBL/GenBank/DDBJ 
under accession number X57792. 
needed  for  the  vegetative  growth  of yeast  cells.  Plasmid 
pFN14 (described in Table II), containing a disrupted copy 
of the BOS1 gene, was constructed in several steps. A  1.1 kb 
HindlII fragment,  marked by the  URA3 gene,  was excised 
from pRB8 (described in Table II) and inserted into pFN8 
Figure 3. Antibody prepared to a TrpE-Bosl hybrid protein recog- 
nizes  a 27-kD yeast protein.  Cells  transformed with a high-copy 
vector (SFNY 59) or with a high-copy vector containing the BOS1 
gene (SFNY 61) were broken with glass beads as described before 
(Ruohola et at.,  1988). One OD599 unit of cells were subjected  to 
electrophoresis  on  12.5%  SDS polyacrylamide slab  gel and im- 
munoblotted with preimmune serum (lanes  1 and 2), immune se- 
rum (lanes 3 and 4) and 5 #g/ml of affinity-purified antibody (lanes 
5 and 6). 
(described in Fig. 5) at a unique Eco RI site (shown in Fig. 
1) internal to the BOS1 gone. A 5.4-kb Sph I fragment, con- 
taining the disrupted gone, was removed from pFN14 and in- 
troduced into NY 363 (Table I), a homozygous Ura- diploid 
yeast strain. This Sph I fragment recombined with one of  two 
copies of the BOS1 gene present in diploid cells,  replacing 
one copy with the disrupted copy that contains URA3.  Ura  + 
Figure 4.  The Bosl protein sedi- 
ments  with  yeast  membranes. 
Wild-type yeast cells (200 OD599 
units; SFNY26-6A) grown to early 
log phase in YPD medium were 
converted  to  spheroplast s  and 
lysed  as described  before  (Ruo- 
hola  and  Ferro-Novick,  1987). 
The lysate was centrifuged at 450 g 
for  5  rain  to  remove  nonlysed 
cells and the supernatant was cen- 
trifuged  at  100,000  g  for  1  h. 
The high-speed  pellet was resuspended  in the same volume as the 
supernatant and aliquots  of each fraction were heated  in sample 
buffer at 100°C.  Samples were subjected  to electrophoresis  on a 
12.5%  SDS  polyacrylamide slab  gel  and  immunoblotted  with 
5 #g/ml  of affinity-purified  antibody.  The  lysate  (lane  I)  and 
100,000 g  supernatant (lane  2) were loaded at the same volume 
while  the  100,000  g pellet  (lane  3) contained twice the volume. 
Lane 4 contains an aliquot of SFNY61 prepared as described in the 
legend to Fig.  3. 
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Figure 5. Construction of  the GALI-BOSI gene fusion. The strategy 
for constructing JSY1, a strain in which the BOS1 gene is under the 
control of the regulatable GAL/promoter, is illustrated. First, to 
construct pYG1, the BOS1 gene was placed behind the GAL/pro- 
moter (Johnston and Davis, 1984; Yocum  et al., 1984) by inserting 
a TaqI-AvalI  fragment containing a portion of BOS1 into the BamHI 
site of pNRB187 (Table II). Then, an Eco RI fragment containing 
BOS1 was excised from pYG1 and inserted into the Eco RI site of 
pNRB103 to yield pYG2. A Kpn I fragment, containing the region 
upstream from BOS1 (checkered), was excised from pFN8 and in- 
serted into the Nhe I site of pYG2 to yield pYG3. Finally, pYG3 was 
cut with Bgl II and partially digested with Eco RI. The resulting 
Eco RI-Bgl II fragment was transformed into NY447 and Ura  + 
transformants were selected. E, Eco RI; B, Bam HI; H, Hind III; 
S, Sph I; K, Kpn I. 
transformants  were  selected,  sporulated,  and  twenty-two 
tetrads were dissected and germinated at 25°C. Two viable 
Ura- spores were recovered from each tetrad, implying that 
the Ura  ÷ spores were inviable. When examined under the 
light microscope, we noted that the inviable spores had initi- 
ated one round of cell division. These findings indicate that 
the BOS1 gene is essential for the mitotic growth of yeast 
cells. 
Identification of the Bosl Protein and its Association 
with Microsomal Membranes 
The nucleotide sequence of the BOSI gene predicts a protein 
of  27-kD. This prediction was tested by raising polyclonal an- 
tibody to a portion of Bosl (amino acid 81-227) fused to the 
E. coli TrpE protein. Western blot analysis revealed that this 
antibody cross-reacts with a 27-kD species (Fig. 3, lanes 3 
and 4) which was not recognized by preimmune serum (Fig. 
3,  lanes  1  and 2).  Affinity-purified antibodies also cross- 
react with this species (Fig. 3, lanes 5 and 6). To confirm that 
the 27-kD species is the Bosl protein, we demonstrated that 
this immunoreactive protein was overproduced in a  strain 
(SFNY61) harboring pFNB61, a high-copy plasmid contain- 
ing the cloned BOS1 gene (Fig. 3, lanes 2, 4, and 6). 
To determine if Bosl is a soluble or membrane-associated 
protein, differential centrifugation studies were used. These 
experiments were performed with wild type yeast sphero- 
plasts that were lysed in a buffer that provides osmotic sup- 
port. The method of cell lysis used in these studies released 
95 % or more of a cytoplasmic marker protein (cytoplasmic 
invertase activity; Goldstein and Lampen, 1975). Nonlysed 
cells were removed from the homogenate by low-speed cen- 
trifugation (450 g) and the 450 g supernatant was centrifuged 
at 100,000 g for 1 h. Western blot analysis revealed that the 
Bosl (Fig. 4, lane 4), residing in the lysate (Fig. 4, lane/), 
sedimented  during  high-speed  (100,000  g)  centrifugation 
(Fig.  4,  compare lanes 2  and 3).  However, on occasion, 
small amounts of this protein were found in the high speed 
supernatant (not shown). Thus, Bosl appears to be associ- 
ated with membranes. We have also performed extractions 
with sodium carbonate, a reagent known to solubilize pro- 
teins from the periphery of membranes (Howell and Palade, 
1982). In an average of  three experiments, we have found that 
60 % of the starting material remained in the pellet, 6 % was 
solubilized, and the rest was not recovered, presumably be- 
cause it was degraded. This observation supports the hypoth- 
esis that Bosl  is a membrane protein. 
Construction of JSY1 
We have demonstrated that the BOS1 gene is essential for the 
vegetative growth of  yeast cells. To determine the phenotypic 
consequences of depleting yeast ceils of the Bosl protein, we 
constructed a strain (JSY1) in which the only copy of BOS1 
was placed under the control of the regulatable GAL/pro- 
moter. In growth medium containing 2% glucose, the syn- 
thesis of Bosl is repressed in this strain. To construct JSY1, 
we placed the BOS1 gene behind the GA/_2 promoter and then 
inserted a piece of flanking DNA upstream from BOS1 to 
facilitate replacement of  the genomic copy with the inducible 
copy of this gene. This region of DNA was excised from the 
vector and then recombined into the genome. The manipula- 
tions involved in the construction of JSY1 are summarized 
in Fig.  5.  Briefly, a Taq I-Ava lI fragment, containing the 
amino-terminal portion of the BOS1 gene, was inserted into 
pNRB187 (described in Table H) behind the GAL/promoter. 
The resulting  GALI-BOS1 fusion was  placed downstream 
from URA3 by inserting an Eco RI fragment isolated from 
pYG1 into the Eco RI site of pNRB103. The region upstream 
of BOS1 was inserted in front of the URA3 gene by ligating 
the Kpn I fragment of pFN8 into the Nhe I site of pYG2. The 
resulting plasmid, pYG3, was digested with Bgl II and par- 
tially digested with Eco RI.  The Eco RI-Bgl II fragment, 
containing the region upstream of BOS1 and the GALI-BOS1 
fusion, was transformed into NY447 and Ura  ÷ transformants 
were selected. 
The growth properties of  one transformant, JSY1, were ex- 
amined on agar plates containing different carbon sources. 
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a partial defect in growth. This growth defect is suppressed when the Gall-Bosl fusion protein is expressed (SFNY87-4D). At 30°C the 
sec22 mutant,  SFNY86-TB (MATa, ura3-52, GAL  +, sec22-3),  displays a partial defect in growth. This growth defect is suppressed when 
the Gall-Bosl fusion protein is expressed (SFNY88-5C). 
JSY1 failed to grow on YPD plates (YP +  2 % glucose) but 
did grow as well as wild type (NY447)  on YP plates sup- 
plemented with 2 % raffinose and 0.5 % galactose. A second 
transformant displayed the same properties. This result was 
anticipated since the BOS1 gene is needed for the vegetative 
growth of yeast cells.  To demonstrate that JSY1  expressed 
the Bosl  protein in a  regulatable manner,  we constructed 
haploid  strains  containing  the  GALI-BOS1  gene fusion in 
combination with either the bet1-1 (SFNY87-4D) or sec22-3 
(SFNY88-5C) mutation. The ability of BOS1 to suppress the 
growth defect associated with each mutation was then tested. 
We observed that the Gall-Bosl fusion protein suppressed 
bet1-1 (SFNY87-4D) on YPGal (2 % galactose) plates at 35°C, 
whereas  sec22-3  (SFNY88-5C)  was  suppressed  at  30°C 
(Fig. 6).  As expected, SFNY87-4D and SFNY88-5C  failed 
to grow on YPD plates at 35°C and 30°C respectively (not 
shown). This suppression was specific to bet1 and sec22, as 
the  Gall-Bosl  fusion  protein  failed to  suppress  sec4 (not 
shown), a mutant blocked in post-Golgi secretion (Salminen 
and Novick,  1987). 
Bosl-depleted Cells Fail to Transport Proteins to 
the Golgi Complex 
The ability of the BOS1  gene to  specifically suppress the 
growth  and  secretion defect of mutants blocked in transit 
from the ER to the Golgi complex suggests that this gene en- 
codes a protein that functions in this process. If  the Bosl pro- 
tein is a necessary component of the yeast secretory appara- 
tus, depletion of this gene product should block secretion. 
To test this prediction,  we examined the transport of two 
different proteins in Bosl-depleted cells: a precursor of the 
yeast pheromone pro-or-factor and the vacuolar protease car- 
boxypeptidase Y (CPY). To repress the synthesis ofBosl, ex- 
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Figure 7. Growth of JSYI and NY447 in minimal medium contain- 
hag 2% glucose. JSY1 and wild type (NY447) ceils were grown at 
30°C to early exponential phase in minimal  medium containing 
100  /zM  ammonium sulfate,  0.5%  galactose,  2%  raffinose,  20 
/zg/ml histidine, and 40/~g/rnl uracil. At the zero time point the ceils 
were pelleted and resuspended in minimal medium containing 100 
ttM ammonium sulfate, 2 % glucose,  20 ttg/ml histidine,  and 40 
~g/mi uracil  (OD599 =  0.025). After a  12-h incubation at 30°C, 
JSY1 failed to continue growing. 
Figure 8.  The 26-kD form of 
pro-a-factor  accumulates  in 
JSY1  when  synthesis  of the 
Bosl protein is repressed. Syn- 
thesis of the BOS1 gene prod- 
uct was repressed in JSY1 cells 
as described in Materials and 
Methods.  One  OD599 unit  of 
ceils,  depleted  of  the  Bosl 
protein, was radiolabeled with 
200 #Ci of [35S]sulfate for 45 
min at 30°C. The bet and sec 
mutants were incubated for 15 
rain at 37°C and radiolabeled 
at this temperature for  45 rain. 
Radiolabeled cells  were con- 
verted  to  spheroplasts,  lysed 
and pro-a-factor was immuno- 
precipitated.  The solubilized 
immunoprecipitates were ana- 
lyzed by SDS-PAGE (12.5 %): 
(lane  1)  wild type (NY477); 
(lane 2) BOS1 under the con- 
trol  of  the  GAL/ promoter 
(JSY1); (lane 3) betl-1 (ANY 
113); (lane 4) sedS-I (NY432). 
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accumulates  in  JSY1 when 
synthesis of  the Bosl protein is 
repressed. Cells were radiola- 
beled  as described  in Mate- 
rials and Methods. The radio- 
labeled  cells  were converted 
to spheroplasts, lysed and the 
forms of CPY were immuno- 
precipitated  and analyzed by 
SDS-PAGE (10%): (lane  1) 
wild type (NY447); (lane 2) 
BOS1 under the control of the 
GAL/ promoter 0SY1); (lane 
3) bet1-1 (ANY 113); (lane 4) 
secl8-1  (NY432). 
ponentially grown JSY1 cells were shifted into fresh medium 
containing glucose.  After a  12-h incubation at  30°C,  the 
ODs99 of JSY1  failed to increase,  whereas wild-type cells 
(NY447) continued to grow (Fig. 7). Lysates prepared from 
JSY1  cells, treated in this way, did not contain detectable 
amounts of the 27-kD Bosl protein when analyzed on West- 
ern blots (not shown). 
The transit of pro-u-factor through the secretory pathway 
can be assessed by monitoring several processing events. 
The secreted pheromone a-factor, initially synthesized as a 
large 19-kD precursor molecule, contains a signal sequence, 
a hydrophilic proregion and four tandem repeats of the ma- 
ture peptide CKurjan and Herskowitz,  1982).  As  a  conse- 
quence of signal sequence cleavage and the addition of three 
N-linked core oligosaccharide units, prepro-a-factor is con- 
verted to a  26-kD species in the lumen of the ER.  These 
N-linked oligosaccharide chains are extended when pro-a- 
factor is transported to the Golgi complex. Pro-a-factor is 
then processed to the mature form in the trans-Golgi  com- 
plex or in secretory vesicles enroute to the plasma mem- 
brane (Julius et al., 1984). To determine if the Bosl protein 
is required for pro-a-factor transport, JSY1  and wild-type 
cells (NY447)  were labeled with  [3sS]sulfate  after a  12-h 
incubation in medium containing 2% glucose. Radiolabeled 
cells, converted to spheroplasts, were lysed in detergent and 
pro-a-factor was  immunoprecipitated.  Bosl-depleted cells 
accumulated the 26-kD species, as well as partially glyco- 
sylated forms of pro-a-factor (Fig.  8, lane 2). These forms 
did not accumulate in wild-type cells (Fig. 8, lane/), but did 
accumulate in two previously identified mutants  (bet1  and 
sec18) that block export from the ER to the Golgi complex 
(Fig. 8, lanes 3 and 4). This finding indicates that yeast cells, 
lacking the Bosl protein, fail to transport pro-a-factor to the 
Golgi apparatus. 
We also examined the processing of CPY in Bosl-depleted 
cells.  ProCPY is synthesized as a  zymogen with an 8-kD 
proregion and a  cleavable signal sequence (Blachly-Dyson 
and Stevens, 1987; Hemmings et al., 1981). This protein ac- 
quires N-linked core oligosaccharides in the lumen of the 
ER, which are extended in the Golgi complex, before CPY 
is activated by the PEP4 gene product in the vacuole (Hem- 
mings et al., 1981; Stevens et al., 1982). Secretory mutants 
that disrupt protein export at or before the Golgi complex 
(Stevens et al.,  1982;  Newman  and  Ferro-Novick,  1987; 
Deshaies  and Schekman,  1987;  Toyn et al.,  1988) fail to 
transport CPY to the vacuole. To determine if Bosl-depleted 
cells block CPY transport, lysates were prepared from cells 
radiolabeled  with  [~sS]sulfate  as  described  above.  JSY1, 
wild-type, and mutants cells, that block export from the ER 
to the Golgi complex, were examined. The sec18 (Fig.  9, 
lane 4) and betl  mutants (Fig. 9, lane 3) were found to ac- 
cumulate the 67-kD pl form of CPY at 37°C (Stevens et al., 
1982; Newman and Ferro-Novick, 1987). This form (Fig. 
9,  lane  2)  was  also  synthesized  in  Bosl-depleted  cells, 
whereas the mature form (61-kD) was synthesized in wild 
type cells (Fig. 9, lane/). Therefore,  in the absence of Bosl 
protein, CPY fails to be transported to the Golgi apparatus. 
In the experiments described above, JSY1 cells were ana- 
lyzed subsequent to a long incubation (12 h) in glucose con- 
taining growth medium. If the observed block in transport 
is a direct consequence of the loss of Bosl, the onset of this 
defect should correlate with the depletion of this protein. 
JSY1 and wild type ceils were incubated for varying periods 
Figure 10 The depletion of Bosl protein from JSYI cells is coinci- 
dent with the block in secretion. Cells were grown overnight at 
30°C in minimal medium containing 100 izM ammonium sulfate, 
0.5% galactose,  2%  raflinose,  40  /~g/ml uracil,  and  20  #g/ml 
L-histidine. Early log phase cells were resuspended in the same 
medium,  containing 2%  glucose, as described  in Materials and 
Methods.  Aliquots of cells (one ODs~ unit) were removed at 0 
(lane 1 ), 2 (lane 2), 4 (lane 3), 6 (lane 4), 8 (lane 5), 10 (lane 6), 
and  12 (lane 7) h, analyzed for the presence of Bosl protein by 
Western blot analysis, and examined for a defect in pro-t~-factor  (p- 
c~-f) transport,  as described in the legend to Fig. 8 and Materials 
and Methods. A defect in pro-u-factor transport was detected at the 
8-h time point, when cell viability was approximately the same as 
time zero. Cell viability was measured by plating an aliquot of  cells 
onto YP plates, containing 0.5% galactose and 2% raflinose, and 
comparing the number of viable cells obtained to that of the zero 
time point. 
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medium and the presence of Bosl protein was measured at 
each time point. At time zero, JSY1 cells contained approxi- 
mately four times more Bosl protein than NY447 (not shown). 
Although the level of Bosl remained unaltered in wild type, 
this protein was depleted from JSY1 subsequent to 8 h in glu- 
cose containing medium (see Fig. 10 A, lane 5). During this 
incubation, aliquots of cells were removed at various times, 
radiolabeled, and pro-a-factor transport was monitored as 
described above. A secretion defect was first observed at 8 h 
(Fig.  10 B, lane 5), when the cells were viable and in ex- 
ponential growth (Fig. 7). The same results were obtained 
when CPY transport was examined (not shown). Thus, the 
export defect observed  in  JSY1  cells  correlates  with  the 
depletion of Bosl protein. 
Boed-depleted Cells Accumulate ER and Patches 
of Small Vesicles 
The previously identified sec and bet mutants,  that block 
transport from the ER to the Golgi complex, accumulate an 
extensive network of ER at their restrictive growth tempera- 
ture. Vesicles, 40-60 nm in size, also accumulate in some 
of these mutants (Novick et al.,  1980; Newman and Ferro- 
Novick, 1987). To determine the morphological consequences 
of depleting yeast cells of the Bosl protein, thin sections of 
cells lacking Bosl were examined by electron microscopy. In 
wild type, tubules of ER in contact with the nuclear envelope 
or at the periphery of  cells were observed (Fig. 11 A). In con- 
trast,  JSY1  cells incubated for 10 h  in glucose containing 
growth medium accumulated an extensive network of ER 
(Fig.  11 B). The lumen of the ER and the nuclear envelope 
were also dilated in these cells and patches of vesicles 50-60 
nm in size were found in the cytoplasm (Fig.  11, B and C). 
These vesicles were comparable in size to the vesicles that 
accumulate in several other mutants (betl, bet2, sec17, sec18, 
and sec22) blocked in transport from the ER to the Golgi 
complex (Novick et al.,  1980; Newman and Ferro-Novick, 
1987). Thus, thin section analysis confirms the findings dis- 
cussed above and indicates that, in the absence of Bosl, pro- 
tein  transport  is  blocked before entry into  the  Golgi  ap- 
paratus. 
Discussion 
In this report, we describe the characterization of BOS1, an 
essential gene identified as a stage-specific suppressor of  ER- 
accumulating mutants (Newman et al., 1990). The ability of 
this gene to specifically suppress bet1 and sec22 suggests that 
its product acts in conjunction with the Betl and Sec22 pro- 
teins to perform an interrelated function. Thus, Bosl itself 
is likely to be required for ER to Golgi transport. To address 
this hypothesis, we have determined the phenotypic conse- 
quences of  depleting yeast ceils of the Bosl protein. This was 
achieved by constructing JSY1,  a  strain in which the sole 
copy of  BOS1 was placed under the control of  the regulatable 
GAL/promoter. In growth medium containing glucose, JSY1 
fails  to  synthesize Bosl.  As  a  consequence,  pro-or-factor 
transport is blocked and unprocessed precursors accumulate 
within the cell (Figs. 8 and 10).  Cells depleted of the Bosl 
protein also fail to transport CPY to the vacuole (Fig. 9). 
The extent of precursor processing of proCPY and pro-t~- 
factor is consistent with a block in ER to Golgi transport and 
Figure 11. EM analysis of BOSl-depleted yeast cells. Samples were 
prepared for electron microscopic analysis as described by New- 
man and Ferro-Novick (1987). Thin-section analysis of wild-type 
(A) and BOS/-depleted cells, JSY1 (B).  C is a high magnification 
of the small vesicles observed in Bosl-depleted cells, er, endoplas- 
mic reticulum; n, nucleus; sv, small vesicles. 
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the notion that this gene product plays a direct role in secre- 
tion. Based on this observation, we anticipate that condi- 
tional lethal temperature-sensitive mutants in bosl  should 
display a secretion defect within minutes after a shift to the 
restrictive temperature. This hypothesis will be tested, in the 
future, by constructing mutations in this gene. 
Although no significant homologies were revealed when 
Bosl was compared with other proteins in the National Bio- 
medical  Research  Foundation  protein  sequence  library, 
DNA sequence analysis has revealed that BOS1 shares cer- 
tain structural features with BET1. Both genes contain in- 
trons and encode small proteins that are hydrophilic at their 
amino-termini, with a stretch of hydrophobic amino acids at 
or near the carboxy end of the protein. The Betl protein is 
structurally similar to synaptobrevin, a constituent of synap- 
tic vesicles (Newman, A., and S. Ferro-Novick, unpublished 
observations). Like synaptobrevin, Betl has significant  alpha- 
helical potential in the middle region of the protein. In addi- 
tion, a sequence of four amino acids "klkr" which is con- 
served in synaptobrevin homologues found in a variety of 
species, is also present in Betl at the appropriate distance 
from the hydrophobic carboxy terminus (Baumert et al., 
1989;  Sudhof et al., 1989).  The BOS1 gene does not, how- 
ever,  contain this consensus sequence. 
Selection schemes previously used in yeast have led to the 
isolation of a large number of secretory mutants that disrupt 
vesicular transport at various stages of the pathway (Novick 
et al., 1980; Newman and Ferro-Novick, 1987). The distri- 
bution of mutant alleles, conferring a block in ER to Golgi 
transport,  suggested that additional genes whose products 
mediate transport at this stage of the pathway remained to be 
identified. The BOS1 gene was  isolated (Newman et al., 
1990) by its ability to suppress the growth defect of a known 
ER-accumulating mutant, bet1 (Newman and Ferro-Novick, 
1987). The isolation of BOS1 and the characterization of its 
product has shown that suppression by overexpression is one 
means of identifying a gene whose product performs a func- 
tion related to the gene bearing the original mutation. Sev- 
eral other examples have been reported whereby this tactic 
has led to the isolation of a gene that encodes a protein which 
functions in the same process (Salminen and Novick, 1987; 
Dietzel and Kurjan, 1987; Bender and Pringle, 1989; Nakano 
and Muramatsu, 1989).  Thus, this approach provides a use- 
ful means of identifying  new components that mediate secre- 
tion in yeast. 
Does the 27-kD membrane protein encoded by the BOS1 
gene product mediate vesicle budding or subsequent stages 
of ER to Golgi transport? A morphological analysis of Bosl 
depleted cells may provide a clue. Cells depleted of this pro- 
tein accumulate a network of dilated ER (Fig. 11) as well as 
50-nm vesicles. Vesicles of  this size also accumulate in sec17, 
sec18 and sec22, three mutants that disrupt transit from the 
ER to the Golgi complex (Novick et al., 1980). Recently, it 
was proposed that these 50 nm vesicles constitute an inter- 
mediate compartment that mediates transport at this stage of 
the pathway (Kaiser and Schekman, 1990).  Thus, transport- 
incompetent vesicles, that fail to fuse with the Golgi appara- 
tus, may bud from donor membranes in Bosl depleted cells. 
Alternatively, Bosl may control the attachment or fusion of 
intermediate transport  vesicles with  their  acceptor  com- 
partment. 
The yeast in vitro transport assay wili enable us to address 
the role of the Bosl protein in secretion. Transit from the ER 
to the Golgi complex is achieved in vitro when donor ER 
membranes are incubated with a yeast lysate in the presence 
of an ATP-regenerating system (Ruohola et al., 1988; Baker 
et al.,  1988).  This event is mediated by carrier vesicles, a 
short lived intermediate which is normally present in cells 
in low amounts. The ER to Golgi transport assay has enabled 
us to trap this intermediate in vitro, facilitating the isolation 
of this transient organelle (Groesch et al., 1990).  Currently, 
we are purifying these vesicles to determine if Bosl is a true 
constituent of this compartment. Now that we have devel- 
oped an assay that permits the isolation of functional carrier 
vesicles, we can definitively determine whether the BOS1 
gene product controls vesicle budding or later  stages  of 
transport. 
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